A Pilot Study of the VosCryoTM Breathalyser in Lung Cancer
This study, called CryoPilot, is happening at Weston Park Cancer Centre in Sheffield. Researchers are using a new breathalyser device, the VosCryoTM, to collect breath samples from people with advanced lung cancer. The main goal is to see if these breath samples contain enough cells, like lung cells or even tiny cancer cells, that can be analysed. This could eventually lead to a new, easy way to diagnose lung cancer without invasive procedures. They will also compare these samples with those from healthy relatives to see if the breath test can tell the difference between healthy and cancerous states. Taking part involves giving a breath sample, which is quick and simple.
At a glance
What is this study about?
This study is looking into a new way to help diagnose lung cancer more easily in the future. Lung cancer is a serious illness, and finding it early often means treatments are more effective. However, current ways to diagnose it can sometimes be uncomfortable or involve complicated procedures. Researchers are hoping to find a simpler method.
The study uses a special device called the VosCryoTM breathalyser. It's a bit like a regular breathalyser, but its purpose is to collect tiny samples from your breath. When you breathe out, particularly after a deep breath, your breath contains tiny droplets of fluid from your lungs. These droplets can carry cells and other important information from inside your body. The researchers want to see if this device can collect enough of these cells from people with advanced lung cancer to be useful for testing.
In this study, they will compare breath samples from two groups: people with advanced lung cancer and healthy relatives who do not have cancer. By comparing the samples, they hope to learn if the VosCryoTM breathalyser can pick up differences that show whether someone has lung cancer or not. If successful, this simple breath test could one day become part of how doctors check for lung cancer, potentially making diagnosis quicker and less invasive.', 'eligibility_plain': 'To join this study, you need to be at least 16 years old and be able to understand and sign a consent form. You might be eligible if you have advanced lung cancer (either non-small cell or small cell lung cancer) that has not yet been treated with chemotherapy or radiation. Even if you had early-stage lung cancer that was treated in the past, you might still be able to join. If you have advanced lung cancer that has spread outside the chest, you may still be eligible if your doctor thinks any previous treatments for spread, like radiation to a bone, won't affect the breath sample.
Alternatively, if you are a healthy relative or friend of someone with advanced lung cancer, you could be eligible for the 'control group'. This means you shouldn't have a history of lung cancer or any other type of cancer (unless it was a very common skin cancer or a very early cancer that was completely treated at least two years ago).
Anyone who has a current chest infection or any difficulty giving a breath sample would not be able to take part. Also, if your cancer started somewhere else in your body and has spread to your lungs (rather than being lung cancer itself), you would not be able to participate. You must be able to understand and agree to take part.
Key takeaways
- Researchers are testing a new breath test for lung cancer in Sheffield.
- The test uses a device called VosCryoTM to collect breath samples.
- It aims to see if breath samples contain cells that could help diagnose lung cancer.
- Comparing samples from people with lung cancer to healthy relatives is key.
- Participation involves a single, quick, and easy breath sample.
- This study could lead to simpler lung cancer diagnosis in the future.
Who may be eligible?
Age 16 Years to any · Sex: ALL
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you at least 16 years old?
- Do you have advanced lung cancer that hasn’t been treated with chemotherapy or radiotherapy yet, OR are you a healthy relative/friend of someone with advanced lung cancer (with no history of cancer yourself, except for certain skin cancers treated over 2 years ago)?
- Are you able to clearly understand information and sign a consent form?
- Do you currently NOT have a chest infection or cold?
- Are you able to provide a breath sample easily?
What does participation involve?
If you decide to take part in this study, you'll visit Weston Park Hospital in Sheffield. First, a doctor or nurse will explain the study to you in detail and answer any questions you have. If you're happy to proceed, you'll be asked to sign a consent form. After that, you will simply provide a breath sample using the VosCryoTM device. This is a very quick and simple process, similar to breathing into a breathalyser for about a minute. There are no other visits, medications, or long-term follow-ups required for this pilot study, so your total participation will only be during that single hospital visit.
Potential risks and benefits
Locations (1)
- Weston Park Cancer CentreVerified postcodeSheffield, United Kingdom
Common questions
What is the VosCryoTM breathalyser?
It's a special device that collects a tiny sample of liquid from your breath when you breathe into it. Researchers want to see if this sample contains useful cells.
Is giving a breath sample painful?
No, it's a very simple and painless process, much like breathing into a regular breathalyser for about a minute.
Who is running this study?
The study is called CryoPilot and is being run at Weston Park Cancer Centre in Sheffield, UK.
Will this study help me directly?
While this study won't directly improve your current health, your participation will help scientists learn more about lung cancer diagnosis for the future.
How long will it take to participate?
Your participation will only take place during a single visit to the hospital, usually just a few minutes to give the breath sample after consenting.
How to find out more
Robin J Young, MBChB MRCP PhD
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.